山东药玻
(600529)
| 流通市值：210.10亿 | | | 总市值：210.10亿 |
| 流通股本：6.64亿 | | | 总股本：6.64亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,106,144,387.57 | 960,691,339.67 | 1,378,886,187.3 | 1,352,049,912.52 |
| 应收票据及应收账款 | 1,630,343,249.69 | 1,614,971,994.43 | 1,590,006,813.89 | 1,477,823,026.81 |
| 其中：应收票据 | 651,782,941.4 | 633,213,952.45 | 658,563,337.64 | 606,167,382.11 |
| 应收账款 | 978,560,308.29 | 981,758,041.98 | 931,443,476.25 | 871,655,644.7 |
| 应收款项融资 | 113,640,169.3 | 105,104,184.55 | 90,784,786.27 | 72,836,142.41 |
| 预付款项 | 68,132,953.41 | 100,846,452.69 | 84,012,577.56 | 76,842,219.7 |
| 其他应收款合计 | 2,175,436.66 | 2,596,903.65 | 2,808,255.08 | 2,236,949.9 |
| 存货 | 1,115,819,247.9 | 1,142,431,214.34 | 1,149,678,867.25 | 1,209,908,569.25 |
| 其他流动资产 | 2,997,072.76 | 18,622,588.47 | 6,457,237.68 | 27,782,984.6 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 5,356,088,463.32 | 5,500,500,045.65 | 5,447,562,092.77 | 5,320,914,051.87 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 50,000 | 50,000 | 50,000 | 50,000 |
| 固定资产 | 2,344,758,102.91 | 2,404,402,268.37 | 2,352,840,528.99 | 2,345,815,674.51 |
| 在建工程 | 551,782,328.41 | 468,254,827.43 | 497,237,540.64 | 475,182,312.37 |
| 无形资产 | 255,334,665.3 | 257,007,232.14 | 258,687,477.17 | 260,372,996.19 |
| 递延所得税资产 | 30,962,885.19 | 32,572,120.72 | 31,881,194.13 | 32,005,327.11 |
| 其他非流动资产 | 479,992,716.14 | 405,966,856.79 | 342,072,856.75 | 349,912,167.88 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 3,662,880,697.95 | 3,568,253,305.45 | 3,482,769,597.68 | 3,463,338,478.06 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 9,018,969,161.27 | 9,068,753,351.1 | 8,930,331,690.45 | 8,784,252,529.93 |
| 流动负债: | | | | |
| 短期借款 | 5,224,907.96 | 10,820,497.49 | 6,760,731.99 | 5,201,945.09 |
| 应付票据及应付账款 | 1,232,520,348.54 | 1,279,580,406 | 1,368,552,440.52 | 1,417,910,091.21 |
| 其中：应付票据 | 581,723,383.16 | 649,936,688.53 | 730,914,799.85 | 722,207,607.52 |
| 应付账款 | 650,796,965.38 | 629,643,717.47 | 637,637,640.67 | 695,702,483.69 |
| 合同负债 | 57,622,412.77 | 63,773,227.89 | 57,618,079.27 | 51,036,681.34 |
| 应付职工薪酬 | 18,323,911.34 | 17,097,391.81 | 15,165,599.35 | 16,023,710.44 |
| 应交税费 | 51,741,778.79 | 52,052,810.58 | 43,545,860.36 | 46,959,539.28 |
| 其他应付款合计 | 144,550,759.19 | 335,318,962.85 | 108,758,771.92 | 107,894,268.53 |
| 应付股利 | - | 199,084,233.9 | - | - |
| 其他流动负债 | 80,111,604.72 | 107,155,504.86 | 144,627,768.67 | 118,601,022.12 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,590,095,723.31 | 1,865,798,801.48 | 1,745,029,252.08 | 1,763,627,258.01 |
| 非流动负债: | | | | |
| 递延收益 | 53,781,535.99 | 55,502,954.59 | 57,224,373.19 | 58,945,791.79 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 53,781,535.99 | 55,502,954.59 | 57,224,373.19 | 58,945,791.79 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,643,877,259.3 | 1,921,301,756.07 | 1,802,253,625.27 | 1,822,573,049.8 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 663,614,113 | 663,614,113 | 663,614,113 | 663,614,113 |
| 资本公积 | 2,687,120,521.29 | 2,687,120,521.29 | 2,687,120,521.29 | 2,687,120,521.29 |
| 专项储备 | 73,743,761.57 | 74,832,699.22 | 75,359,724.85 | 75,481,230.33 |
| 盈余公积 | 469,422,189.93 | 469,422,189.93 | 469,422,189.93 | 469,422,189.93 |
| 未分配利润 | 3,481,191,316.18 | 3,252,462,071.59 | 3,232,561,516.11 | 3,066,041,425.58 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 7,375,091,901.97 | 7,147,451,595.03 | 7,128,078,065.18 | 6,961,679,480.13 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 7,375,091,901.97 | 7,147,451,595.03 | 7,128,078,065.18 | 6,961,679,480.13 |
| 负债和股东权益合计 | 9,018,969,161.27 | 9,068,753,351.1 | 8,930,331,690.45 | 8,784,252,529.93 |
| 公告日期 | 2023-10-19 | 2023-08-29 | 2023-04-25 | 2023-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |